Delivery Order SPE2DB24D3015-SPE2DB25FGAFC
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency on July 28, 2025, to supply 60 tablets of Lamictal 150 mg with a ceiling value of $12,599.98. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of July 29, 2025. The contract serves as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Lamictal 100 mg tablets (quantity 100) with a ceiling value of $27,252.70. This is a firm fixed price delivery order with no set-aside designation, executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical supply will be performed...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lamictal (lamotrigine) 25 mg tablets in quantities of 100 units. This competitive, non-set-aside contract was executed on September 23, 2025, with a firm fixed price ceiling value of $3,822.90 and an ultimate completion date of September 24, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,622.55 to AmerisourceBergen Drug Corp for the supply of Lamictal 200 mg tablets (60-count units) on August 6, 2025, with completion scheduled for August 7, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Lamictal 150 mg on August 13, 2025, with a ceiling value of $2,273.15. This is a firm fixed-price delivery order with an ultimate completion date of August 14, 2025. The contract is not set-aside and represents a competitive award to the prime contractor. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a $1,757.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Lamictal 200 mg, with an ultimate completion date of October 30, 2025. This non-set-aside competitive award was issued on October 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills this...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,982.15, is for the delivery of Lamictal 100 mg tablets. It is a firm-fixed-price contract with an ultimate completion date of April 22, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $2,047.16 to AmerisourceBergen Drug Corp for 60 tablets of Lamictal 150 mg on August 11, 2025, with completion scheduled for August 12, 2025. This delivery order was awarded on a firm fixed price basis without set-aside designation, indicating competitive award to this established pharmaceutical vendor. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $42,766.34 to AmerisourceBergen Drug Corp for the supply of Lamictal XR 200 mg tablets (30-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product LAMICTAL 150 MG TABLET 60S. The contract has a potential value of $1,211.96 and a performance period through February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB25FGAFCDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,579.11 to AmerisourceBergen Drug Corp for the supply of Lamictal 25 mg tablets (100 count) on July 22, 2025, with a completion date of July 23, 2025. The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The contract is classified as a child award under a larger contract vehicle, reflecting the company's role as a primary pharmaceutical supplier to military and federal healthcare systems. This delivery order falls under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications and medical supplies to support military healthcare programs worldwide. Lamictal, a neurological treatment, exemplifies the diverse pharmaceutical portfolio the contractor delivers under its federal agreements. The award supports the Defense Health Agency and other government healthcare systems requiring reliable pharmaceutical supply chains for military personnel and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/22/25 |